Secure shopping
Healthcare and pharma
The Pharma & Healthcare industry is of vital importance for human and economic development, providing a wide range of goods and services relevant to the promotion of health at all stages in the healthcare process – from prevention and treatment to rehabilitation and palliative care. It is one of the fastest-growing industries, supported by profound demographic changes, the rising incidence of non-communicable diseases, and surging per capita health spending in both developed and emerging markets. The industry is also one of the major innovators, with increasing expenditures on development of new molecules, biotechnology and adoption of new technologies that provide advanced healthcare and ensure the longevity of the population.
The Pharma & Healthcare industry comprises the manufacture of pharmaceuticals for human and veterinary use, medical equipment and related supplies. It also includes providers of ambulatory health services, medical and diagnostic laboratories, hospitals, and nursing and residential care facilities.
Since 2017, China has been the second largest pharmaceutical market, after the US, according to Deloitte, and at the end of 2024 it had a share of 10% of the global pharmaceutical market. According to the National Bureau of Statistics (NBS), the ...
View more details
China's healthcare system is hospital-centric, and most inpatient and outpatient care in the country is delivered by public hospitals and basic medical institutions. However, due to growing demand for specialised healthcare and high-quality medical ...
View more details
Since 2017, China has been the second largest pharmaceutical market, after the US, according to Deloitte, and at the end of 2024 it had a share of 10% of the global pharmaceutical market. According to the National Bureau of Statistics (NBS), the ...
View more details
China's healthcare system is hospital-centric, and most inpatient and outpatient care in the country is delivered by public hospitals and basic medical institutions. However, due to growing demand for specialised healthcare and high-quality medical ...
View more details
Since 2017, China has been the second largest pharmaceutical market, after the US, according to Deloitte, and at the end of 2024 it had a share of 10% of the global pharmaceutical market. According to the National Bureau of Statistics (NBS), the ...
View more details
China's healthcare system is hospital-centric, and most inpatient and outpatient care in the country is delivered by public hospitals and basic medical institutions. However, due to growing demand for specialised healthcare and high-quality medical ...
View more details
Since 2017, China has been the second largest pharmaceutical market, after the US, according to Deloitte, and at the end of 2024 it had a share of 10% of the global pharmaceutical market. According to the National Bureau of Statistics (NBS), the ...
View more details
China's healthcare system is hospital-centric, and most inpatient and outpatient care in the country is delivered by public hospitals and basic medical institutions. However, due to growing demand for specialised healthcare and high-quality medical ...
View more details
China's healthcare system is hospital-centric, and most of the inpatient and outpatient care in the country is delivered by public hospitals and basic medical institutions. On the other hand, due to the growing demand for specialised healthcare and ...
View more details
According to Deloitte, China has been the second largest pharmaceutical market after the US since 2017 and had a market share of 11% in the global pharmaceutical market by the end of 2022. According to the National Bureau of Statistics (NBS), the ...
View more details